Outlook Therapeutics, Inc. · NASDAQ:OTLK

GMS Ventures & Investments reported a 22.90% stake in Outlook Therapeutics, Inc. (Schedule 13D/A)

Event May 28, 2026 · Filed Jun 1, 2026

GMS Ventures & Investments reported a 22.90% stake in Outlook Therapeutics, Inc., 37,580,638 shares, with active intent on May 28, 2026. Filed Jun 1, 2026 (Schedule 13D/A).

Stake
22.90%
Shares
37,580,638
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
GMS Ventures & Investments22.90%37,580,638
SUKHTIAN GHIATH M.22.90%37,580,638

Source

View original at SEC

Related